IL6 and intestinal neoplasm: ADAM17 is required for EGFR-induced intestinal tumors, apparently by shedding EGFR ligands to activate EGFR-dependent interleukin (IL)-6 synthesis in colonic myloid cells, which via IL-6 trans-signaling induces epithelial tumor formation [6].